MARSHA STAPLETON: Open Payments
NPI 1497138887 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 89 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $1,180 · 2025 $1,891
Food & beverage: $1,887Education: $4
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $679 |
| Alkermes, Inc. | 20 | $398 |
| Otsuka America Pharmaceutical, Inc. | 16 | $259 |
| ABBVIE INC. | 9 | $144 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Corium, LLC | 5 | $102 |
| Lundbeck LLC | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $29 |
| Tris Pharma Inc | 1 | $23 |
Products named: Auvelity, ARISTADA, REXULTI, VRAYLAR, COBENFY, Azstarys, ABILIFY ASIMTUFII, Qelbree.
Industry payments across LA — which companies pay providers there.
